Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly
- 1 December 2002
- Vol. 21 (3-4) , 303-311
- https://doi.org/10.1016/s0264-410x(02)00451-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- Active Bacterial Core Surveillance of the Emerging Infections Program NetworkEmerging Infectious Diseases, 2001
- Clinical Efficacy of Pneumococcal Vaccine in the ElderlyThe American Journal of Medicine, 1997
- Immunogenicity of pneumococcal revaccination in patients with chronic diseaseArchives of internal medicine (1960), 1994
- Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendationsPublished by American Medical Association (AMA) ,1993
- Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccinationVaccine, 1991
- Pneumococcal Antibody Levels One Decade After Immunization of Healthy Adults**Mufson MA, Krause HE, Schiffman G, Hughey D: Decline in pneumococcal antibody levels one decade after administration of polysaccharide vaccine. Clin Res 34:222A, 1986.The Lancet Healthy Longevity, 1987
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsNew England Journal of Medicine, 1986
- Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccineArchives of internal medicine (1960), 1986
- Pneumococcal infectionsPublished by American Medical Association (AMA) ,1981